We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A one year follow-up study of natural killer and dendritic cells activities in multiple sclerosis patients receiving glatiramer acetate (GA).
- Authors
Høglund, Rune A; Holmøy, Trygve; Harbo, Hanne F; Maghazachi, Azzam A
- Abstract
Multiple sclerosis (MS) is a chronic inflammatory, demyelinating and neurodegenerative disease. It is thought to be mediated by CD4(+) Th1/Th17 cells. More recently, cells of the innate immune system such as dendritic cells (DCs) and natural killer (NK) cells have been in focus. Glatiramer acetate (GA) is an approved drug for treating MS patients.
- Publication
PloS one, 2013, Vol 8, Issue 4, pe62237
- ISSN
1932-6203
- Publication type
Journal Article
- DOI
10.1371/journal.pone.0062237